BioSante Freed From 2 Investor Suits Over Libido Drug

Law360, New York (September 11, 2013, 6:55 PM ET) -- An Illinois federal judge tossed a pair of shareholder suits Wednesday over statements BioSante Pharmaceuticals Inc. made about clinical trials for an experimental women's libido drug, finding that neither suit clearly spelled out what the company had allegedly done wrong.

In a pair of decisions, U.S. District Judge Joan B. Gottschall dismissed a shareholder class action over disappointing clinical results for the company's LibiGel testosterone gel treatment for women with low sex drive and a derivative complaint over the same events.

In the shareholder class action,...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required

Case Information

Case Title

Lauria v. BioSante Pharmaceuticals, Inc. et al

Case Number

1:12-cv-00772

Court

Illinois Northern

Nature of Suit

850(Securities/Commodities)

Judge

Honorable Joan B. Gottschall

Law360 Coverage

Date Filed

February 2, 2012


Case Title

Weinstein v. Sullivan et al

Case Number

1:12-cv-03480

Court

Illinois Northern

Nature of Suit

160(Contract: Stockholders Suits)

Judge

Honorable Joan B. Gottschall

Date Filed

May 7, 2012

Sections

Law Firms Mentioned

Government Agencies Mentioned

Related Articles